Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
11.30
+0.33 (3.01%)
Jul 14, 2025, 4:00 PM - Market closed
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $871.85 million as of July 14, 2025. Its market cap has increased by 60.95% in one year.
Market Cap
871.85M
Enterprise Value
448.79M
1-Year Change
60.95%
Ranking
Category
Stock Price
$11.30
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $871.85M, an increase of 86.49%. That is a compound annual growth rate of 9.34%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |